CVS Health Corp vs Yum China Holdings Inc — how do they compare? CVS Health Corp trades at $88.26 (market cap $112.29B), while Yum China Holdings Inc trades at $43.21 (market cap $14.11B). The key difference: CVS Health Corp is far larger — about 8× Yum China Holdings Inc's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Yum China Holdings Inc for 77 Days on average.
| CVS | YUMC | |
|---|---|---|
Market Cap | $112.29B | $14.11B |
Volume | 7,763,676 | 2,350,650 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $57.95 |
52-Week Low | $70.08 | $39.98 |
Typical Hold Time | 83 Days | 77 Days |
Enterprise Value | $174.64B | $15.02B |
Dividend Yield | 3.03% | 2.78% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
YUMC trades at $40.65 with minimal daily movement (+0.07%). The stock shows strong fundamental performance with consistent earnings beats (Q4 2025-Q2 2026) and solid profitability metrics (ROE 17.5%, net margin 7.84%). Recent business developments include the acquisition of Pizza Hut brand ownership in mainland China and expansion of Pizza Hut Burger Bar to 300 locations. Technical indicators show bearish momentum with the stock trading near key support at $40.
YUMC presents a compelling value opportunity with reasonable valuation multiples (P/E 15.3, P/S 1.2) and strong analyst support (73.68% buy ratings). Upside potential exists from continued store expansion and brand innovation, though investors should monitor China's consumer spending trends and competitive pressures in the restaurant sector. The stock's current technical weakness may offer entry points for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →